All treatments
Treatment
Folinezuur Sandoz 10 mg/ml clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic confirmatory (Phase III)
Perioperative versus adjuvant FOLFIRINOX for resectable pancreatic cancer: the PREOPANC-3 study
This study looks at treating pancreatic cancer with strong chemotherapy (FOLFIRINOX) either before or after surgery. Researchers want to see if giving it before surgery helps people live longer. It's for adults with pancreatic cancer that hasn't spread and can be removed by surgery.
For: Non-metastatic resectable pancreatic cancerNetherlands · Sweden - Ongoing, recruitingTherapeutic confirmatory (Phase III)
THE (COST)EFFECTIVENESS OF NEOADJUVANT FOLFIRINOX VERSUS NEOADJUVANT GEMCITABINE BASED CHEMORADIOTHERAPY AND ADJUVANT GEMCITABINE FOR (BORDERLINE) RESECTABLE PANCREATIC CANCER (PREOPANC-2 STUDY)
This study looks at two different ways to treat pancreatic cancer that can or might be surgically removed. It compares using a specific combination of powerful medicines before surgery to another powerful medicine combined with radiation before surgery, followed by more medicine. The main goal is to see which treatment helps people live longer.
For: non-metastatic (borderline) resectable pancreatic cancerNetherlands